MoneyWorks4Me

Dr Lal Pathlabs informs about impact of covid 19 pandemic

02 Jun 2020 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Dr Lal Pathlabs has informed that it has submitted the disclosure of material impact of COVID-19 pandemic on the business and operations of the Company.

The above information is a part of company’s filings submitted to BSE.


Peers